440 filings
Page 5 of 22
DEFA14A
yj3 ms6bso29xlq0hw
3 Jun 22
Additional proxy soliciting materials
6:06am
8-K
9ewgpbgh ej3o9tosp7
2 Jun 22
Termination of a Material Definitive Agreement
5:25pm
8-K
9dpny
16 May 22
AcelRx Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
7:35am
8-K
ycc0j0a
9 May 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:21pm
EFFECT
2vkzrhukw8kdqjpw4z
4 May 22
Notice of effectiveness
12:15am
424B7
y0hxs7 5f9lv5wnzsc4e
3 May 22
Prospectus with selling stockholder info
5:24pm
8-K
l10jfo7wr6thpi5mn
31 Mar 22
Other Events
4:05pm
8-K
dyj8q9
10 Mar 22
AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results
4:06pm
8-K
dn7z92bwj0 7ahvi
1 Mar 22
Departure of Directors or Certain Officers
4:10pm
8-K
fzwfbcz
14 Feb 22
Departure of Directors or Certain Officers
12:00am
D
u9j jfj5xoivwcxuu
24 Jan 22
$5.96M in equity, sold $5.16M, 32 investors
4:21pm
8-K
w7mrax9p45qo
12 Jan 22
AcelRx Pharmaceuticals Announces the Closing of its Acquisition of Lowell Therapeutics
4:01pm
8-K
dcfkbfpf0eas6kbe
3 Dec 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:48pm